%PDF-1.4
%
59 0 obj
<>
endobj
56 0 obj
<>
endobj
124 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-04-13T14:37:45Z
2024-03-29T06:25:45-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-29T06:25:45-07:00
application/pdf
Heather
2003-289.may
uuid:224864aa-1dd2-11b2-0a00-fb09276d7200
uuid:224864ac-1dd2-11b2-0a00-b80000000000
endstream
endobj
45 0 obj
<>
endobj
46 0 obj
<>
endobj
60 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 29 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 31 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 33 0 R/Type/Page>>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 35 0 R/Type/Page>>
endobj
15 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 37 0 R/Type/Page>>
endobj
18 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 39 0 R/Type/Page>>
endobj
146 0 obj
[150 0 R]
endobj
147 0 obj
<>stream
q
0 0 612 792 re
W n
BT
0.8 g
/T1_0 18 Tf
0.6114 0.7912 -0.7912 0.6114 35.383 35.2215 Tm
(Personal, non-commercial use only. The Journal of Rheumatology. Copyrigh\
t \251 2004. All rights reserved.)Tj
ET
Q
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 72 714.5293 Tm
(long-term analysis of 164 applications in 82 patients. Br )Tj
0 -1.25 TD
(J Rheumatol 1993;32:383-6.)Tj
-1.8 -1.25 Td
[(17.)-550.1 (Jahangier ZN, Jacobs JW)91.7 (, van Isselt JW)91.7 (, Bijlsma JW)91.7 (. Persistent)]TJ
1.8 -1.25 Td
(synovitis treated with radiation synovectomy using yttrium-90: a)Tj
T*
(retrospective evaluation of 83 procedures for 45 patients. Br )Tj
T*
(J Rheumatol 1997;36:861-9.)Tj
-1.8 -1.25 Td
[(18.)-550.1 (Bridgman JF)79.7 (, Bruckner F)79.7 (, Eisen )17.7 (V)128.9 (,)-0.1 ( )17.7 (T)35 (ucker )54.8 (A, Bleehen NM.)]TJ
1.8 -1.25 Td
(Irradiation of synovium in the treatment of rheumatoid arthritis.)Tj
0 Tc T*
(QJM 1973;42:357-67.)Tj
-0.00011 Tc -1.8 -1.25 Td
[(19.)-550.1 (Onetti CM, Guti\216rrez E, Hliba E, )54.8 (Aguirre CR. Synoviorthesis with)]TJ
0 Tc 0 Tw 5.2 0 0 5.2 72 617.1693 Tm
(32)Tj
-0.00011 Tc 0.02499 Tw 8 0 0 8 77.1999 614.5293 Tm
(P-colloidal chromic phosphate in rheumatoid arthritis \321 clinical,)Tj
-0.65 -1.25 Td
(histopathologic and arthrographic changes. J Rheumatol)Tj
0 Tc 0 Tw T*
(1982;9:229-38.)Tj
-0.00011 Tc 0.02499 Tw -1.8 -1.25 Td
[(20.)-550.1 (Jahangier ZN, Moolenbur)17.7 (gh JD, Jacobs JWG, Serdijn J, Bijlsma)]TJ
1.8 -1.25 Td
[(JWJ. )17.7 (The ef)17.7 (fect of radiation synovectomy in patients with persistent)]TJ
T*
[(arthritis: a prospective study)64.8 (. Clin Exp Rheumatol 2001;19:417-24.)]TJ
-1.8 -1.25 Td
[(21.)-550.1 (Kampen )17.7 (WU, Brenner )17.7 (W)91.8 (, Kroeger S, Sawula JA, Bohuslavizki KH,)]TJ
1.8 -1.25 Td
(Henze E. Long-term results of radiation synovectomy: a clinical)Tj
0 Tc T*
[(follow-up study)64.9 (. Nucl Med Commun 2001;22:239-46.)]TJ
-0.00011 Tc -1.8 -1.25 Td
[(22.)-550.1 (Erken EHW)91.7 (. Radiocolloids in the management of hemophilic)]TJ
1.8 -1.25 Td
(arthropathy in children and adolescents. Clin Orthop )Tj
0 Tc 0 Tw T*
(1991;264:129-35.)Tj
-0.00011 Tc 0.02499 Tw -1.8 -1.25 Td
[(23.)-550.1 (Fernandez-Palzzi F)79.7 (. Radioactive synoviorthesis in haemophilic)]TJ
1.8 -1.25 Td
[(haemarthrosis. Rheum )54.8 (Arth Rheumatol 1990;13:251-60.)]TJ
-1.8 -1.25 Td
[(24.)-550.1 (Steinbrocker O, )17.7 (T)35 (raeger C, Batterman R. )17.7 (Therapeutic criteria in)]TJ
1.8 -1.25 Td
[(rheumatoid arthritis. JAMA)-220.2 (1949;140:659-62.)]TJ
-1.8 -1.25 Td
[(25.)-550.1 (Johnson LS, )36.8 (Y)99.8 (anch JC, Shortkrof)17.7 (f S, Barnes CL, Spitzer )54.8 (AI, Sledge)]TJ
1.8 -1.25 Td
[(CB. Beta-particle dosimetry in radiation synovectomy)64.8 (. Eur J Nucl)]TJ
0 Tc T*
(Med 1995;22:977-88.)Tj
-0.00011 Tc -1.8 -1.25 Td
[(26.)-550.1 (Mens JMA. Correlation of joint involvement in rheumatoid arthritis)]TJ
1.8 -1.25 Td
(and in ankylosing spondylitis with the synovial:cartilaginous surface)Tj
T*
[(ratio of various joints. )54.8 (Arthritis Rheum 1987;30:359-60.)]TJ
-1.8 -1.25 Td
[(27.)-550.1 (ICRP)-238.2 (60. Recommendations of the ICRP; 21, No. 1-3. London:)]TJ
1.8 -1.25 Td
[(Per)17.7 (gamon Press; 1991.)]TJ
-1.8 -1.25 Td
[(28.)-550.1 (Mettler F)73.9 (A)-220.1 (Jr)39.7 (, )17.6 (W)39.8 (iest PW)91.7 (, Locken JA, Kelsey CA. CT)-257.3 (scanning:)]TJ
1.8 -1.25 Td
(patterns of use and dose. J Radiol Prot 2000;20:353-9.)Tj
-1.8 -1.25 Td
[(29.)-550.1 (Menkes CJ. Radioisotope synoviorthesis in rheumatoid arthritis.)]TJ
1.8 -1.25 Td
(Rheumatol Rehabil 1979; Suppl:45-6.)Tj
-1.8 -1.25 Td
[(30.)-550.1 (Gobel D, Gratz S, von Rothkirch )17.7 (T)74 (, Becker )17.7 (W)91.8 (,)-0.1 ( )17.7 (W)39.8 (illert HG.)]TJ
1.8 -1.25 Td
(Radiosynoviorthesis with rhenium-186 in rheumatoid arthritis: a)Tj
T*
(prospective study of three treatment regimens. Rheumatol Int)Tj
0 Tc 0 Tw T*
(1997;17:105-8.)Tj
-0.00011 Tc 0.02499 Tw 31.2 51.25 Td
[(31.)-550.1 (Gratz S, G\232bel D, Behr )17.7 (TM, Herrmann )54.8 (A, Becker )17.7 (W)91.9 (. Correlation)]TJ
1.8 -1.25 Td
[(between radiation dose, synovial thickness and ef)17.7 (ficacy of )]TJ
T*
(radiosynoviorthesis. J Rheumatol 1999;26:1242-9.)Tj
-1.8 -1.25 Td
[(32.)-550.1 (Houvenagel E, Deboury L, Leloire O, et al. )54.8 (Anomalies )]TJ
1.8 -1.25 Td
(cytog\216n\216tiques apr\217s synoviorth\217se isotopique au cours de la\
)Tj
T*
(polyarthrite rhumato\225de. Rev Rhumatisme 1991;58:31-4.)Tj
-1.8 -1.25 Td
[(33.)-550.1 (Manil L, )17.7 (V)128.9 (oisin P)110.7 (,)-0.1 ( )54.8 (Aubert B et al. Physical and biological dosimetry)]TJ
1.8 -1.25 Td
[(in patients under)17.7 (going radiosynoviorthesis with erbium-169 and)]TJ
T*
(rhenium-186. Nucl Med Commun 2001;22:405-16.)Tj
-1.8 -1.25 Td
[(34.)-550.1 (Noble J, Jones )54.8 (AG, Davies MA, Sledge CB, Kramer RI, Livni E.)]TJ
1.8 -1.25 Td
(Leakage of radioactive particle systems from a synovial joint)Tj
T*
(studied with a gamma camera. Its application to radiation )Tj
T*
[(synovectomy)64.8 (. J Bone Joint Sur)17.7 (g )54.8 (Am 1983;65:381-9.)]TJ
-1.8 -1.25 Td
[(35.)-550.1 (V)59.8 (irkkunen M, Krusium FE, Heiskannen )17.7 (T)74 (. Experiences of)]TJ
1.8 -1.25 Td
[(intra-articular administration of radioactive gold. )54.8 (Acta Rheumatol)]TJ
0 Tc T*
(Scand 1967;13:81-91.)Tj
-0.00011 Tc -1.8 -1.25 Td
[(36.)-550.1 (T)69.9 (opp JR, Cross EG, Fam )54.8 (AG. )17.7 (T)35 (reatment of persistent knee ef)17.7 (fusion)]TJ
1.8 -1.25 Td
[(with intra-articular gold. Can Med )54.8 (Assoc J 1975;1)36.8 (12:1085-9.)]TJ
-1.8 -1.25 Td
[(37.)-550.1 (T)69.9 (opp JR, Cross EG. )17.7 (The treatment of persistent knee ef)17.7 (fusion with)]TJ
1.8 -1.25 Td
[(intra-articular radioactive gold: preliminary report. Can Med )54.8 (Assoc )]TJ
0 Tc T*
(J 1970;102:709-14.)Tj
-0.00011 Tc -1.8 -1.25 Td
[(38.)-550.1 (Correns HJ, Zielke )54.8 (A, Unverricht )54.8 (A, Stiller KJ. Intra-articular )]TJ
1.8 -1.25 Td
[(treatment of chronic polyarthritis with coarse colloidal )54.8 (Au 198.)]TJ
T*
(Radiobiol Radiother 1969;10:505-9.)Tj
-1.8 -1.25 Td
[(39.)-550.1 (Clunie G, Lui D, Cullum I, Edwards JCW)91.7 (, Ell PJ. )]TJ
1.8 -1.25 Td
(Samarium-153-particulate hydroxyapatite radiation synovectomy:)Tj
T*
(biodistribution data for chronic knee synovitis. J Nucl Med)Tj
0 Tc 0 Tw T*
(1995;36:51-7.)Tj
-0.00011 Tc 0.02499 Tw -1.8 -1.25 Td
[(40.)-550.1 (Zalutsky MR, )17.7 (V)110.8 (enkatesan PP)110.7 (, English RJ, Shortkrof)17.7 (f S, Sledge CB,)]TJ
1.8 -1.25 Td
(Adelstein SJ. Radiation synovectomy with )Tj
0 Tc 0 Tw 5.2 0 0 5.2 475.1993 427.1693 Tm
(165)Tj
-0.00011 Tc 0.02499 Tw 8 0 0 8 482.9992 424.5293 Tm
(Dy-FHMA: lymph)Tj
-18.3749 -1.25 Td
(node uptake and radiation dosimetry calculations. Int J Nucl Med)Tj
0 Tc T*
(Biol 1986;12:457-65.)Tj
-0.00011 Tc -1.8 -1.25 Td
[(41.)-550.1 (Mumper RJ, Mills BJ, R)39.7 (yo UY)128.8 (, Jay M. Polymeric microspheres for)]TJ
1.8 -1.25 Td
(radionuclide synovectomy containing neutron-activated )Tj
T*
(holmiun-166. J Nucl Med 1992;33:398-402.)Tj
ET
0 0 0 1 K
54 54 m
558 54 l
S
BT
/T1_2 1 Tf
8 0 0 8 54.5 35.9844 Tm
(van der Zant, et al: Radiation synovectomy)Tj
0 Tc 0 Tw 61.4375 -0.0313 Td
(901)Tj
ET
0 0 0 0 k
/GS0 gs
109.22 59.08 396.48 -10.83 re
f*
0.5 w
109.22 59.08 396.48 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_3 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2004. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_4 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
39 0 obj
<>stream
8;Z\6!E-fh%+G5@R-t#j/BOm?ZI02lMdasiNap8t;dIJW'chR8A[
Tmn,-2@!V3$[i,7768@^oP^j3Oa8QqfabE"d4Fg_;].94UTk:U')?XY199/H4,$ZI
kJ8;oj1;8^'`3F')Hck\!Khiq5d3Ll['Gt1D7W^9j:^"Z)Y$E]V$uFLY,Y$/U&>cI
Z$273`A&tml4ZR76,p>CV6(_DG>'H)^0XS4P?I;+1ao7(lsUp-/):eihh#JqoWr3R
-s[:!'CcA`P!Bf!=9]mLGc5Q=E3GDJ9m(#]FLC<1=c&YSnKuG0!fZL'B1DW1hCL%t
.]K/QK#Ebj-e[!WORJt:^;>8d.pAQZdbaY)H'GMrkKMK+?j'Ml$hONr"INc<26:_,
5GqK,Wo0?d/?NE=;LtdiT[XH.XK^kKkY:\3FUZT[8X2$c;4C&?B]j/JJl5cI=:'TX
Co^S0A2>iAXCgp#o`Hso?l_k!!i[grT*PVQ*4:7RrVPQ_,Ae8,%@Gl3dOM),Jo#J!
5PB?c1bX3s39@c1p$r6q,W`\kF.&8T\gOHnL'uB5d!h-Z!+b,3'sTT.<7iFU]ZibY
^sTe#gu%&=Z=V4F/R,Z"g#"_NDmoj0M0NNYp1jBX60iCYRXGSE7Er+N~>
endstream
endobj
43 0 obj
[/Indexed/DeviceRGB 255 42 0 R]
endobj
42 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
111 0 obj
<>
endobj
67 0 obj
<>
endobj
62 0 obj
<>
endobj
98 0 obj
<>
endobj
129 0 obj
<>
endobj
63 0 obj
<>
endobj
90 0 obj
<>stream
HU{PSwM.A ,Uw-huh)D Kg%ȣ`AŭB]|[Tku]fsݨ3͙s~?YZ`8;:\* ĥoc3-7Yf6kmښhmɸ[;(glҭWE[fYxl|#qk?}kg(])LLV-o߿}QO*RżCtQfD̊y 3\}1O($q Ը#